AtaiBeckley (ATAI) Total Liabilities (2020 - 2026)

AtaiBeckley (ATAI) posted quarterly Total Liabilities of $66.1 million for Q1 2026, down 6.54% quarter-over-quarter from $70.7 million in Q4 2025.

AtaiBeckley (ATAI) Total Liabilities (2020 - 2026) Analysis & Trends

AtaiBeckley's Total Liabilities history runs 3 years deep, the most recent figure standing at $66.1 million for Q1 2026.

In Q1 2026, Total Liabilities changed N/A year-over-year to $66.1 million; the TTM figure through Mar 2026 stood at $66.1 million (changed N/A YoY), while the FY2025 annual figure was $70.7 million, up 65.11% from the prior year.
Total Liabilities for Q1 2026 stood at $66.1 million, down from $70.7 million in the prior quarter.
Over five years, Total Liabilities peaked at $79.9 million in Q3 2025 and troughed at $885000.0 in Q1 2021.
A 5-year average of $38.9 million and a median of $40.1 million in 2023 frame the typical range for Total Liabilities.
Peak annual rise in Total Liabilities reached 65.11% in 2025, while the deepest fall reached 65.11% in 2025.
AtaiBeckley's Total Liabilities stood at $42.8 million in 2024, then jumped by 65.11% to $70.7 million in 2025, then slipped by 6.54% to $66.1 million in 2026.
Business Quant data shows ATAI's Total Liabilities at $66.1 million in Q1 2026, $70.7 million in Q4 2025, and $42.8 million in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Liabilities (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	7.18 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	10.02 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	1.62 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	1.72 Bn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	4.00 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	7.02 Mn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	10.03 Bn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	4.20 Bn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	1.35 Bn
10	AtaiBeckley	2.69 Bn	2.69 Bn	-	79.91 Mn

Download Data